Papillary lesions of the breast: imaging findings and diagnostic challenges

Author(s):  
Pooja Jagmohan ◽  
Felicity Jane Pool ◽  
Thomas Choudary Putti ◽  
Jill Wong
2011 ◽  
Vol 62 (1) ◽  
pp. 60-72 ◽  
Author(s):  
Anabel M. Scaranelo ◽  
Bridgette Lord ◽  
Riham Eiada ◽  
Stefan O. Hofer

Advances in breast imaging over the last 15 years have improved early breast cancer detection and management. After treatment for breast cancer, many women choose to have reconstructive surgery. In addition, with the availability of widespread genetic screening for breast cancer, an increasing number of women are choosing prophylactic mastectomies and subsequent breast reconstruction. The purpose of this pictorial essay is to present the spectrum of imaging findings in the reconstructed breast.


1994 ◽  
Vol 162 (3) ◽  
pp. 617-619 ◽  
Author(s):  
E B Mendelson ◽  
N Doshi ◽  
B C Grabb ◽  
W I Goldfarb

2020 ◽  
Author(s):  
Xiaohui Li ◽  
Hua Gao ◽  
Minling Xu ◽  
Yang Wu ◽  
Dezong Gao

Abstract Background: The management of papillary lesions of the breast remains controversial, and thus, we assessed the value of vacuum-assisted excision (VAE)-guided ultrasound in the diagnosis and treatment of breast papillary lesions. Methods: We retrospectively reviewed the data of 108 patients with papillary lesions diagnosed using VAE between August 2014 and January 2019. Cases without postoperative breast imaging in the follow-up were excluded, and 85 cases were eligible for the study. The follow-up period ranged from 6 to 53 months, with 38 months on average. All the papillary lesions were located away from the skin or nipple with a size less than or equal to 30 mm, and the lesions categorized as C2-4b were completely excised using VAE. All VAEs were per­formed using an 8-gauge vacuum-assisted biopsy nee­dle under the guidance of ultrasound using a 10 MHz linear probe. Results: Most patients with breast papillary lesions were asymptomatic (56.5%), and when the size of the breast papillary lesion was more than 20 mm on ultrasound imaging, atypical hyperplasia may have been concomitant. Breast lesions might have been pathologically diagnosed as papilloma after biopsy when they were categorized as BI-RADS 4a on ultrasound images. The rate of underestimation was 7.7% in papillary lesions diagnosed with VAE, and the recurrence rate of papilloma after VAE was low. Conclusions: Breast papilloma was a common lesion on ultrasonographic screening, and VAE was applicable for completely excising small papillomas, even papillomas with atypical hyperplasia, to obtain an accurate diagnosis with a low rate of underestimation and recurrence. We believe that papilloma diagnosed by VAE might not require immediate excision, and imaging follow-up may be safe for at least 3 years.


2007 ◽  
Vol 48 (1) ◽  
pp. 27-29 ◽  
Author(s):  
M. L. Ruiz-Delgado ◽  
J. A. López-Ruiz ◽  
B. Eizaguirre ◽  
A. Saiz ◽  
E. Astigarraga ◽  
...  

2019 ◽  
Vol 27 (7) ◽  
pp. 736-743 ◽  
Author(s):  
Lianqun Qiu ◽  
Daniel D. Mais ◽  
Marlo Nicolas ◽  
Jennifer Nanyes ◽  
Kenneth Kist ◽  
...  

The histologic distinction between papillary breast lesions remains challenging, especially with core biopsy (CB) specimens. A retrospective review of the clinical, imaging, and histologic findings was performed for patients with papillary breast lesions on CB from 2013 to 2017. The interpretation accuracy was expressed as upgrade rate relative to the excision diagnosis. Diagnostic reproducibility with and without immunohistochemistry was analyzed as interobserver variability among 3 board-certified pathologists. Among 57 papillary lesions with biopsies and excisions available for review, the upgrade rates were 0% for benign papilloma, 30% for papilloma with atypical ductal hyperplasia, and 25% for papilloma with ductal carcinoma in situ, resulting in an overall upgrade rate of 11.1%. There were no statistical differences between patients in an upgrade group and others, when comparing the patient age, clinical presentation, BI-RADS (Breast Imaging Reporting and Database System) category, location, and histologic grade. The overall interobserver variability of the 60 consecutive core biopsies of papillary breast lesions by morphology alone was in the “substantial” agreement range (κ = 0.79, 86% agreement), with an excellent κ score of 0.88 for papilloma (92% agreement). “Substantial” and “fair” κ values were seen for papilloma with atypical ductal hyperplasia/ductal carcinoma in situ (0.74, 84% agreement) and invasive carcinoma (0.40, 60% agreement). Use of immunohistochemical stains improved the κ values into “excellent” range (0.92, 94% agreement). Our study favors a conservative approach in the management of benign papillomas, at least in cases of good radiologic-pathologic concordance. Papillary breast lesions with atypia/malignancy show lower diagnostic reproducibility on CB, and utility of immunohistochemistry is recommended in challenging cases.


Author(s):  
Yukun Gao ◽  
E Jane Karimova ◽  
Jordana Phillips ◽  
Valerie Fein-Zachary ◽  
Vandana Dialani ◽  
...  

Abstract In the United States, silicone and saline breast implants with their familiar radiologic appearance are the mainstays of breast augmentation. However, less well-known sequelae of unconventional injected materials introduced for cosmetic and noncosmetic purposes may also be encountered on breast imaging—for example, free silicone, paraffin and/or oil, polyacrylamide gel, autologous fat, and hyaluronic acid, which are encountered in the setting of breast augmentation. Breast injection of go-yak is not cosmetic but also results in characteristic imaging findings. Breast changes due to extravasation of chemotherapy or interstitial brachytherapy can mimic the appearance of injected noncosmetic materials. Because many of these materials can mimic or obscure imaging findings of breast cancer, it is important to recognize their varied appearances and the limitations of imaging alone in delineating breast injection material from cancer. Given the relatively uncommon incidence of injected materials into the breast, this article aims to review the imaging appearance in order to aid radiologists in maximizing cancer detection and ensuring optimal patient management.


2020 ◽  
Vol 15 (11) ◽  
pp. 2494
Author(s):  
Misugi Urano ◽  
Fatmaelzahraa Abdelfattah Denewar ◽  
Haruka Okabe ◽  
Hirokazu Komatsu ◽  
Yumi Wanifuchi-Endo ◽  
...  

1996 ◽  
Vol 69 (823) ◽  
pp. 678-680 ◽  
Author(s):  
F Başaran Demİrkazik ◽  
Ö Başkan ◽  
Ü Aydingöz ◽  
T Tacal ◽  
P Firat

2016 ◽  
Vol 30 (2) ◽  
pp. 228-233
Author(s):  
Ronilda Lacson ◽  
Martha E. Goodrich ◽  
Kimberly Harris ◽  
Phyllis Brawarsky ◽  
Jennifer S. Haas

Sign in / Sign up

Export Citation Format

Share Document